Virtual Screening to Identify Calcium Channel Blockers

Despite the promise of T-type calcium channels as a drug target, the first marketed blocker was withdrawn due to adverse drug interactions. Can virtual screening of potential ligands help identify drug–drug interactions earlier in the discovery process? This exclusive study examines the possibilities.

Read more